---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-067328"
form_type: "8-K"
ticker: "ADVB"
cik: "0001941029"
company_name: "Advanced Biomed Inc."
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T02:39:55.481040+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Advanced Biomed receives Nasdaq bid price deficiency notice; has 180 days to regain compliance

## Summary
- Nasdaq notified ADVB on July 18, 2025, of bid price below $1.00 for 32 consecutive business days.
- Company has until Jan 14, 2026 to regain compliance; must close at $1.00+ for 10 consecutive days.
- If not cured, ADVB may get an extra 180 days if it meets other Nasdaq initial listing standards.
- Company may consider a reverse stock split or other options to remedy the deficiency.
- Common stock continues trading under symbol ADVB on Nasdaq Capital Market with no immediate impact.

## SEC filing metadata
- accession: 0001213900-25-067328
- form_type: 8-K
- ticker: ADVB
- cik: 0001941029
- company_name: Advanced Biomed Inc.
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1941029/000121390025067328/0001213900-25-067328-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1941029/000121390025067328/ea025015701-8k_advanced.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-067328
- JSON: https://secwatch.observer/filing/0001213900-25-067328.json
- Plain text: https://secwatch.observer/filing/0001213900-25-067328.txt

## Key facts
- Listing & Compliance Notices
  Advanced Biomed Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: July 18, 2025, Advanced Biomed Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 32 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The Notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade o
  evidence_url: https://www.sec.gov/Archives/edgar/data/1941029/000121390025067328/0001213900-25-067328-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.